Kriska BioTech ApS: Financial statements 2024
CVR: 37591971
Source: annual report 2024, Danish Business Authority
01/10/2023 – 30/09/2024
Kriska BioTech ApS (CVR 37591971) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -13,410 and a net result of DKK -44,384 compared with DKK -61,277 the year before. Equity in the 2024 report amounted to DKK -375,410.
- Gross Profit
- DKK -13,410
- Profit/Loss
- DKK -44,384
- Equity
- DKK -375,410
- Total Assets
- DKK 165,889
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -13 t. | -44 t. | -375 t. | - |
| 2023 | - | -26 t. | -61 t. | -331 t. | - |
| 2022 | - | -88 t. | -120 t. | -270 t. | - |
| 2021 | - | 39 t. | 128 | -149 t. | 1 |
| 2020 | - | -27 t. | -55 t. | -150 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Kriska BioTech ApS has published its annual report for 2023. Gross profit came to DKK -26,043, and the net result was DKK -61,277.
About Kriska BioTech ApS
Kriska BioTech ApS is a Danish company of the type Anpartsselskab based in Gedsted, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Hans Karsten Kristoffersen. The company is owned by Hans Karsten Holding ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK -25,405 and a net result of DKK -49,612 compared with DKK -44,384 the year before. Equity in the 2025 report amounted to DKK -425,023.